People

Glenn Mersky

Glenn Mersky

Bioinformatics Engineer

I obtained my Master’s degree in Computational Biomedicine and Biotechnology from the University of Pittsburgh in 2021 where I worked in conjuction with the Pittsburgh Supercomputing Center. There I helped develop a model of a mouse’s neuromuscular junction using stochastic computational modeling to be used in evaluating a novel treatment for Lambert-Eaton myasthenic syndrome. As an undergraduate, I collaborated with other researchers at the University of Pittsburgh Drug Discovery Institute in developing a combined experimental and computational methodology for streamlining the discovery of combination therapeutics.My primary focus is to continue developing an existing software pipeline, ProTECT (Prediction of T cell epitopes for Cancer Therapy), that has been further fine-tuned for high-performance computing at CHOP, to predict potential neoantigens expressed in a range of tumors directly from patient sequencing data.

Previous Next